30 April 2020
Dow Jones advanced by 2.21% to 24,633 after Gilead’s remdesivir positively succeeded from two drug trials and proved a new treatment for COVID-19 patients.
Research
8 April 2026
Wall Street indexes closed mostly flat on Tuesday, but managed to rebound from intraday...
Research
7 April 2026
In the FY25 period, TBIG recorded revenue of IDR 6.91 trillion, a slight increase of +0...
30 April 2020
Dow Jones advanced by 2.21% to 24,633 after Gilead’s remdesivir positively succeeded from two drug trials and proved a new treatment for COVID-19 patients.
29 April 2020
The Dow Jones dipped 0.13% to 24,101 to end a four-day rally streak as declines in technology ... [Read more...]
28 April 2020
The Dow Jones advanced 1.51% to 24,133 amid the 1Q20 earnings season. Partial states government of the U.S. to reopen the economic lockdown boosted investors?optimism. A glance at the national economy, indices listed on Indonesia Stock Exchange (IDX) recorded minor corrections, i.e., LQ45.
27 April 2020
The Dow Jones picked up 1.11% to 23,775, backed by the rally in Apple inc. (+2.89%) and Microsoft (+1.83%). A glance at the national economy, OJK signed POJK Number 16/POJK.04/2020 on E-AGM. The POJK is a relaxed regulation for companies with respect to the economic lockdown to end COVID-19's vicious spread.
24 April 2020
The Dow Jones closed flat at 0.17 percent to 23,515 after WHO reported Gilead’s COVID-19 drug remdesivir to fail the first random clinic test. In the domestic economy, data of Ministry of Industry disclosed a number of manufacturing industries to prove their agility of dominating export markets regardless the global lockdowns of economic activities.